These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30195864)

  • 1. Recommendations for the post-operative management of an existing Warfarin therapy after lower limb joint arthroplasty.
    Roumeliotis L; Jenkins C; Budithi SC; Karlakki S
    Surgeon; 2019 Aug; 17(4):225-232. PubMed ID: 30195864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of warfarin for venous thromboembolism prophylaxis following knee and hip arthroplasty: results of the Michigan Anticoagulation Quality Improvement Initiative (MAQI2).
    Barnes GD; Kaatz S; Golgotiu V; Gu X; Leidal A; Kobeissy A; Haymart B; Kline-Rogers E; Kozlowski J; Almany S; Leyden T; Froehlich JB
    J Thromb Thrombolysis; 2013 Jan; 35(1):10-4. PubMed ID: 22797905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.
    Gage BF; Bass AR; Lin H; Woller SC; Stevens SM; Al-Hammadi N; Li J; Rodríguez T; Miller JP; McMillin GA; Pendleton RC; Jaffer AK; King CR; Whipple BD; Porche-Sorbet R; Napoli L; Merritt K; Thompson AM; Hyun G; Anderson JL; Hollomon W; Barrack RL; Nunley RM; Moskowitz G; Dávila-Román V; Eby CS
    JAMA; 2017 Sep; 318(12):1115-1124. PubMed ID: 28973620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial.
    Gage BF; Bass AR; Lin H; Woller SC; Stevens SM; Al-Hammadi N; Anderson JL; Li J; Rodriguez T; Miller JP; McMillin GA; Pendleton RC; Jaffer AK; King CR; Whipple B; Porche-Sorbet R; Napoli L; Merritt K; Thompson AM; Hyun G; Hollomon W; Barrack RL; Nunley RM; Moskowitz G; Dávila-Román V; Eby CS
    JAMA; 2019 Sep; 322(9):834-842. PubMed ID: 31479138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin prophylaxis in patients after total knee or hip arthroplasty--international normalized ratio patterns and venous thromboembolism.
    Nordstrom BL; Kachroo S; Fraeman KH; Nutescu EA; Schein JR; Fisher A; Bookhart BK
    Curr Med Res Opin; 2011 Oct; 27(10):1973-85. PubMed ID: 21919556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a nomogram and physician-adjusted dosage of warfarin for prophylaxis against deep-vein thrombosis after arthroplasty.
    Anderson DR; Wilson SJ; Blundell J; Petrie D; Leighton R; Stanish W; Alexander D; Robinson KS; Burton E; Gross M
    J Bone Joint Surg Am; 2002 Nov; 84(11):1992-7. PubMed ID: 12429760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A safe, effective, and easy to use warfarin initiation dosing nomogram for post-joint arthroplasty patients.
    Pendleton RC; Wheeler M; Wanner N; Strong MB; Vinik R; Peters CL
    J Arthroplasty; 2010 Jan; 25(1):121-7. PubMed ID: 19062248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
    Enyart JJ; Jones RJ
    Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Majority of Total Joint Arthroplasties Are Subtherapeutic on Warfarin at Time of Discharge: Another Reason to Avoid Warfarin as a Venous Thromboembolism Prophylaxis?
    Rondon AJ; Goswami K; Tan TL; Shohat N; Parvizi J
    J Arthroplasty; 2018 Sep; 33(9):2787-2791. PubMed ID: 29871833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose oral anticoagulation therapy in Chinese children with congenital heart disease.
    Cheung YF; Leung MP
    J Paediatr Child Health; 1998 Dec; 34(6):563-7. PubMed ID: 9928651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.
    Dager WE
    Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oral diuretics on chronic warfarin therapy: a retrospective study.
    Edwards HD; Webb RD; Conway SE
    Expert Opin Drug Saf; 2012 May; 11(3):375-80. PubMed ID: 21957964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a daily fixed 2.5-mg warfarin dose with a 5-mg, international normalized ratio adjusted, warfarin dose initially following heart valve replacement.
    Ageno W; Turpie AG; Steidl L; Ambrosini F; Cattaneo R; Codari RL; Nardo B; Venco A
    Am J Cardiol; 2001 Jul; 88(1):40-4. PubMed ID: 11423056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin anticoagulation after total hip or total knee replacement: clinical and resource-utilization outcomes in a university-based antithrombosis clinic.
    Nutescu EA; Bautista A; Gao W; Galanter WL; Schumock GT; Mody SH; Bookhart BK; Lambert BL
    Am J Health Syst Pharm; 2013 Mar; 70(5):423-30. PubMed ID: 23413165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.